Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease

Neuroscience Bulletin

Volumn 28, Issue 3, 2012, Pages 253-258

  Du, Xi Xun ^a   Xu, Hua Min ^a   Jiang, Hong ^a   Song, Ning ^a   Wang, Jun ^a   Xie, Jun Xia ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

6 hydroxydopamine; Curcumin; Dopaminergic neurons; Iron; Parkinson's disease

Indexed keywords

CURCUMIN; DOPAMINE; IRON; OXIDOPAMINE; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DOPAMINERGIC NERVE CELL; DRUG STRUCTURE; ELECTROCHEMICAL DETECTION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHIBITION KINETICS; IRON CHELATION; NERVE CELL DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT;

ANIMALS; CURCUMIN; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; FEMALE; IRON; IRON CHELATING AGENTS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSON DISEASE, SECONDARY; RATS; RATS, WISTAR; SUBSTANTIA NIGRA;

EID: 84864658369     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-012-1238-2     Document Type: Article

References (25)

1. Youdim MB, Ben-Shachar D, Riederer P. The role of monoamine oxidase, iron-melanin interaction, and intracellular calcium in Parkinson's disease. J Neural Transm Suppl 1990, 32:239-248.
2. Jiang H, Song N, Wang J, Ren LY, Xie JX. Peripheral iron dextran induced degeneration of dopaminergic neurons in rat substantia nigra. Neurochem Int 2007, 51:32-36.
3. Ke Y, Ming Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003, 2:246-253.
4. Youdim MB, Stephenson G, Ben Shachar D. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28. Ann N Y Acad Sci 2004, 1012:306-325.
5. Onyango IG. Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Neurochem Res 2008, 33:589-597.
6. Sarafanov AG, Todorov TI, Kajdacsy-Balla A, Gray MA, Macias V, Centeno JA. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J Trace Elem Med Biol 2008, 22:305-314.
7. Meissner W, Hill MP, Tison F, Gross CE, Bezard E. Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 2004, 25:249-253.
8. Slikkker W, Youdim M, Palmer GC, Hall E, Williams C, Trembly B. The future of neuroprotection. Ann N Y Acad Sci 1999, 890:529-533.
9. Hanasaki Y, Ogawa S, Fukui S. The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 1994, 16:845-850.
10. Morel I, Lescoat G, Cogrel P, Sergent O, Pasdeloup N, Brissot P, et al. Antioxidant and iron-chelating activities of the flavonoids catechin, quercetin and diosmetin on iron-loaded rat hepatocyte cultures. Biochem Pharmacol 1993, 45:13-19.
11. Santel T, Pflug G, Hemdan NY, Schafer A, Hollenbach M, Buchold M, et al. Curcumin inhibits glyoxalase 1: a possible link to its antiinflammatory and anti-tumor activity. PLoS One 2008, 3:e3508.
12. Masuda T, Hidaka K, Shinohara A, Maekawa T, Takeda Y, Yamaguchi H. Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J Agric Food Chem 1999, 47:71-77.
13. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead-and cadmiuminduced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 2004, 98:266-275.
14. Chen J, Tang XQ, Zhi JL, Cui Y, Yu HM, Tang EH, et al. Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ioninduced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 2006, 11:943-953.
15. Wang J, Du XX, Jiang H, Xie JX. Curcumin attenuates 6- hydroxydopamineinduced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells. Biochem Pharmacol 2009, 78:178-183.
16. Jiang H, Song N, Xu H, Zhang S, Wang J, Xie J. Up-regulation of divalent metal transporter 1 in 6-hydroxydopamine intoxication is IRE/IRP dependent. Cell Res 2010, 20:345-356.
17. Ma ZG, Wang J, Jiang H, Liu TW, Xie JX. Myricetin reduces 6-hydroxydopamine-induced dopamine neuron degeneration in rats. Neuroreport 2007, 18:1181-1185.
18. Dexter DT, Statton SA, Whitmore C, Freinbichler W, Weinberger P, Tipton KF, et al. Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson's disease after peripheral administration. J Neural Transm 2011, 118:223-231.
19. Ak T, Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008, 174:27-37.
20. Messner DJ, Sivam G, Kowdley KV. Curcumin reduces the toxic effects of iron loading in rat liver epithelial cells. Liver Int 2009, 29:63-72.
21. Earl CD, Reum T, Xie JX, Sautter J, Kupsch A, Oertel WH, et al. Foetal nigral cell suspension grafts influence dopamine release in the non-grafted side in the 6-hydroxydopamine rat model of Parkinson's disease: in vivo voltammetric data. Exp Brain Res 1996, 109:179-184.
22. Wang J, Xu HM, Yang HD, Du XX, Jiang H, Xie JX. Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins. Neurochem Int 2009, 54:43-48.
23. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog Neurobiol 2001, 65:135-172.
24. Salazar J, Mena N, Hunot S, Prigent A, Alvarez-Fischer D, Arredondo M, et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci U S A 2008, 105:18578-18583.
25. Jiang H, Luan Z, Wang J, Xie J. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Neurochem Int 2006, 49:605-609.